Article Versions Notes

El-Kafrawy SA, Abbas AT, Sohrab SS, Tabll AA, Hassan AM, Iwata-Yoshikawa N, Nagata N, Azhar EI. Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection. Pharmaceuticals. 2021; 14(6):511. https://doi.org/10.3390/ph14060511

El-Kafrawy, Sherif A., Aymn T. Abbas, Sayed S. Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, Noriyo Nagata, and Esam I. Azhar. 2021. "Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection" Pharmaceuticals 14, no. 6: 511. https://doi.org/10.3390/ph14060511

El-Kafrawy, S. A., Abbas, A. T., Sohrab, S. S., Tabll, A. A., Hassan, A. M., Iwata-Yoshikawa, N., Nagata, N., & Azhar, E. I. (2021). Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection. Pharmaceuticals, 14(6), 511. https://doi.org/10.3390/ph14060511